CorrlensCorrlens
Correlate

Correlation Analysis

Johnson & Johnson vs MetLife, Inc.

JNJ vs MET

+0.129

Weak positive

When one moves up, the other tends to follow.

JNJ logo

Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Market cap 580.4B

MET logo

MetLife, Inc.

MET

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.

Market cap 46.3B · 46,000 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: JNJGray: MET36 of 1,254 points (sampled)

Who Moves First

MET leads JNJ by 6 days

MET tends to move before JNJ.

After testing 13 timing shifts, the strongest relationship was +0.135 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.066

10 periods · Return correlation when both series rose

Both Falling

-0.513

9 periods · Return correlation when both series fell

Diverging

-0.459

16 periods · Return correlation when series moved apart

R-Squared

1.7%

Share of variance in one series explained by the other.

Trend Agreement

58.7%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.074, 0.183]

Scatter

XY Regression

135.5140160180200220240252.649.33505560657075808585.31Johnson & JohnsonMetLife, Inc.Data pointsFit (r = 0.129)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

JNJ logo

Johnson & Johnson

JNJ

Market cap 580.4B

Stock · 1,254 raw → 1,254 prepared

Series B

MET logo

MetLife, Inc.

MET

Market cap 46.3B · 46,000 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

48

Estimated crossover points between normalized spreads.

Slope

0.0547

Linear regression slope.

Intercept

60.5779

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 4 hours ago · ID: stock-jnj-vs-stock-met-daily